The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Microneedle array patches for sustained delivery of fluphenazine: A micron scale approach for the management of schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walker, E. R., McGee, R. E., & Druss, B. G. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2502 · Cited by 2,976
Nanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358
Khatri, D. K., Preeti, K., Tonape, S., Bhattacharjee, S., Patel, M., Shah, S., Singh, P. K., Srivastava, S., Gugulothu, D., Vora, L., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x20666220507022701 · Cited by 75
Self-citation
Research works printed but not linked: 81
- Rubinov, 2013, Schizophrenia and abnormal brain network hubs, Dialogues Clin. Neurosci., 15, 339, 10.31887/DCNS.2013.15.3/mrubinov · DOI · Paper page
- Jablensky, 2010, The diagnostic concept of schizophrenia: its history, evolution, and future prospects, Dialogues Clin. Neurosci., 12, 271, 10.31887/DCNS.2010.12.3/ajablensky · DOI · Paper page
- Chong, 2016, Global economic burden of schizophrenia: a systematic review, Neuropsychiatr. Dis. Treat., 12, 357
- Lehman, 2004, Practice guideline for the treatment of patients with schizophrenia, second edition, Am. J. Psychiatry, 161, 1
- Picco, 2022, 3d-printed implantable devices with biodegradable rate-controlling membrane for sustained delivery of hydrophobic drugs, Drug Deliv., 29, 1038, 10.1080/10717544.2022.2057620 · DOI
- Higashi, 2013, Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review, Ther. Adv. Psychopharmacol., 3, 200, 10.1177/2045125312474019 · DOI · Paper page
- Almond, 2004, Relapse in schizophrenia: costs, clinical outcomes and quality of life, Br. J. Psychiatry, 184, 346, 10.1192/bjp.184.4.346 · DOI · Paper page
- Pennington, 2017, The cost of relapse in schizophrenia, PharmacoEconomics, 35, 921, 10.1007/s40273-017-0515-3 · DOI
- Abruzzo, 2019, Transdermal delivery of antipsychotics: rationale and current status, CNS Drugs, 33, 849, 10.1007/s40263-019-00659-7 · DOI
- Jindal, 2023, Long-acting parenteral drug delivery systems for the treatment of chronic diseases, Adv. Drug Deliv. Rev., 198, 10.1016/j.addr.2023.114862 · DOI
- Vora, 2017, Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: in-vitro characterization and in-vivo pharmacokinetic studies, Eur. J. Pharm. Sci., 107, 78, 10.1016/j.ejps.2017.06.027 · DOI
- Pawar, 2022, Long-acting microspheres of human chorionic gonadotropin hormone: in-vitro and in-vivo evaluation, Int. J. Pharm., 611, 10.1016/j.ijpharm.2021.121312 · DOI
- Moffatt, 2022, Development and evaluation of dissolving microarray patches for co-administered and repeated intradermal delivery of long-acting rilpivirine and cabotegravir nanosuspensions for paediatric HIV antiretroviral therapy, Pharm. Res.
- Tekko, 2021, Novel bilayer microarray patch-assisted long-acting micro-depot cabotegravir intradermal delivery for HIV pre-exposure prophylaxis, Adv. Funct. Mater., 2106999
- Tomita, 2022, Prediction of corresponding dose of transdermal blonanserin to oral dose based on dopamine d2 receptor occupancy: unique characteristics of blonanserin transdermal patch, J. Clin. Psychopharmacol., 42, 260, 10.1097/JCP.0000000000001545 · DOI
- May, 2022, Why drug delivery is the key to new medicines, Nat. Med., 28, 1100, 10.1038/s41591-022-01826-y · doi:10.1038/s41591-022-01826-y
- McAlister, 2021, Directly compressed tablets: a novel drug-containing reservoir combined with hydrogel-forming microneedle arrays for transdermal drug delivery, Adv. Healthc. Mater., 10, 2001256, 10.1002/adhm.202001256 · DOI
- Demartis, 2022, Trilayer dissolving polymeric microneedle array loading Rose Bengal transfersomes as a novel adjuvant in early-stage cutaneous melanoma management, Int. J. Pharm., 627, 10.1016/j.ijpharm.2022.122217 · doi:10.1016/j.ijpharm.2022.122217
- Vora, 2020, Pullulan-based dissolving microneedle arrays for enhanced transdermal delivery of small and large biomolecules, Int. J. Biol. Macromol., 146, 290, 10.1016/j.ijbiomac.2019.12.184 · DOI · Paper page
- Tekko, 2020, Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: potential for enhanced treatment of psoriasis, Eur. J. Pharm. Sci., 152, 10.1016/j.ejps.2020.105469 · DOI · Paper page
- Vora, 2021, Microneedle array systems for long-acting drug delivery, Eur. J. Pharm. Biopharm., 159, 44, 10.1016/j.ejpb.2020.12.006 · DOI · Paper page
- Naser, 2023, Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug, J. Control. Release, 356, 416, 10.1016/j.jconrel.2023.03.003 · DOI
- Paredes, 2022, Ring inserts as a useful strategy to prepare tip-loaded microneedles for long-acting drug delivery with application in HIV pre-exposure prophylaxis, Mater. Des., 224, 10.1016/j.matdes.2022.111416 · DOI
- Peng, 2021, Dissolving microneedle patches loaded with amphotericin B microparticles for localised and sustained intradermal delivery: potential for enhanced treatment of cutaneous fungal infections, J. Control. Release, 339, 361, 10.1016/j.jconrel.2021.10.001 · DOI
- Anjani, 2021, Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs, Eur. J. Pharm. Biopharm., 158, 294, 10.1016/j.ejpb.2020.12.003 · DOI
- Paredes, 2021, Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride, Int. J. Pharm., 606, 10.1016/j.ijpharm.2021.120885 · DOI
- Volpe-Zanutto, 2021, Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii, J. Control. Release, 333, 298, 10.1016/j.jconrel.2021.03.036 · DOI
- Pamornpathomkul, 2018, Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery, Eur. J. Pharm. Sci., 121, 200, 10.1016/j.ejps.2018.05.009 · DOI
- Abd-El-Azim, 2022, Hollow microneedle assisted intradermal delivery of hypericin lipid nanocapsules with light enabled photodynamic therapy against skin cancer, J. Control. Release, S0168-3659
- Clarke, 1981, Fluphenazeve decanoate, 275, 10.1016/S0099-5428(08)60144-6 · doi:10.1016/s0099-5428(08)60144-6
- Luo, 1997, Sensitive method for the simultaneous measurement of fluphenazine decanoate and fluphenazine in plasma by high-performance liquid chromatography with cuolometric detection, J. Chromatogr. B Biomed. Sci. Appl., 688, 303, 10.1016/S0378-4347(96)00287-3 · DOI
- Ramöller, 2022, HPLC-MS method for simultaneous quantification of the antiretroviral agents rilpivirine and cabotegravir in rat plasma and tissues, J. Pharm. Biomed. Anal., 213, 10.1016/j.jpba.2022.114698 · DOI
- Nasiri, 2022, Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery, Drug Deliv. Transl. Res., 12, 881, 10.1007/s13346-021-01107-0 · DOI · Paper page
- Chavda, 2017, A review on novel emulsification technique: a nanoemulsion, research & reviews, J. Pharmacol. Toxicol. Stud., 5, 29
- Wu, 2021, Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye, Eur. J. Pharm. Biopharm., 165, 306, 10.1016/j.ejpb.2021.05.022 · doi:10.1016/j.ejpb.2021.05.022
- Wu, 2022, Nanosuspension-loaded dissolving bilayer microneedles for hydrophobic drug delivery to the posterior segment of the eye, Biomater. Adv., 137, 10.1016/j.bioadv.2022.212767 · doi:10.1016/j.bioadv.2022.212767
- Stewart, 2021, Poly (caprolactone)-based subcutaneous implant for sustained delivery of levothyroxine, Int. J. Pharm., 607, 10.1016/j.ijpharm.2021.121011 · DOI · Paper page
- Peng, 2021, Hydrogel-forming microneedles for rapid and efficient skin deposition of controlled release tip-implants, Mater. Sci. Eng. C, 127, 10.1016/j.msec.2021.112226 · DOI
- Abdelghany, 2019, Nanosuspension-based dissolving microneedle arrays for intradermal delivery of curcumin, Pharmaceutics., 11, 308, 10.3390/pharmaceutics11070308 · DOI
- Cordeiro, 2020, Two-photon polymerisation 3D printing of microneedle array templates with versatile designs: application in the development of polymeric drug delivery systems, Pharm. Res., 37, 10.1007/s11095-020-02887-9 · DOI
- Cárcamo-Martínez, 2021, Enhancing intradermal delivery of tofacitinib citrate: comparison between powder-loaded hollow microneedle arrays and dissolving microneedle arrays, Int. J. Pharm., 593, 10.1016/j.ijpharm.2020.120152 · DOI
- Courtenay, 2020, Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery, J. Control. Release, 322, 177, 10.1016/j.jconrel.2020.03.026 · doi:10.1016/j.jconrel.2020.03.026
- Matar, 2018, Fluphenazine (oral) versus placebo for schizophrenia, Cochrane Database Syst. Rev., 6
- Meyer, 2013, Understanding depot antipsychotics: an illustrated guide to kinetics, CNS Spectr., 18, 55, 10.1017/S1092852913000783 · DOI
- Gorain, 2014, Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats, Colloids Surf. B: Biointerfaces, 115, 286, 10.1016/j.colsurfb.2013.12.016 · DOI · Paper page
- Huang, 1995, The role of the lymphatic system in the presystemic absorption of fluphenazine after intramuscular administration of fluphenazine decanoate in rats, Eur. J. Pharm. Sci., 3, 15, 10.1016/0928-0987(94)00070-G · doi:10.1016/0928-0987(94)00070-g
- Aljabri, 2022, Nanoemulsion: an emerging technology for oilfield applications between limitations and potentials, J. Pet. Sci. Eng., 208, 10.1016/j.petrol.2021.109306 · DOI
- Nasiri, 2021, Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery, Drug Deliv. Transl. Res., 1, 3
- Rai, 2018, Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications, J. Control. Release, 270, 203, 10.1016/j.jconrel.2017.11.049 · DOI · Paper page
- Mahadev, 2022, Fabrication and evaluation of quercetin nanoemulsion: a delivery system with improved bioavailability and therapeutic efficacy in diabetes mellitus, Pharmaceuticals, 15, 70, 10.3390/ph15010070 · DOI
- El-Tokhy, 2021, Transdermal delivery of second-generation antipsychotics for management of schizophrenia; disease overview, conventional and nanobased drug delivery systems, J. Drug Delivery Sci. Technol., 61, 10.1016/j.jddst.2020.102104 · DOI
- Yazgan, 2020, Investigation of antimicrobial properties of sage essential oil and its nanoemulsion as antimicrobial agent, LWT, 130, 10.1016/j.lwt.2020.109669 · DOI
- Bali, 2010, Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe, Colloids Surf. B: Biointerfaces, 76, 410, 10.1016/j.colsurfb.2009.11.021 · DOI · Paper page
- Abu Sharar, 2021, Multiobjective optimization of fluphenazine nanocomposite formulation using nsga-ii method, Mater. Sci.-Pol., 39, 517, 10.2478/msp-2021-0042 · DOI
- Dunne, 2009, Fluphenazine release from biodegradable microparticles: characterization and modelling of release, J. Microencapsul., 26, 403, 10.1080/02652040802396575 · DOI
- Vora, 2018, Novel nanosuspension-based dissolving microneedle arrays for transdermal delivery of a hydrophobic drug, J. Interdiscip. Nanomed., 3, 89, 10.1002/jin2.41 · DOI
- Vora, 2014, Self-assembled nanocomplexes of anionic pullulan and polyallylamine for DNA and pH-sensitive intracellular drug delivery, J. Nanopart. Res., 16, 1, 10.1007/s11051-014-2781-8 · DOI
- Zhao, 2020, Preparation, characterization, and evaluation of antioxidant activity and bioavailability of a self-nanoemulsifying drug delivery system (snedds) for buckwheat flavonoids, Acta Biochim. Biophys. Sin. Shanghai, vol. 52, 1265, 10.1093/abbs/gmaa124 · DOI
- Ramalheiro, 2020, Rapidly dissolving microneedles for the delivery of cubosome-like liquid crystalline nanoparticles with sustained release of rapamycin, Int. J. Pharm., 591, 10.1016/j.ijpharm.2020.119942 · DOI
- Laxmi, 2015, Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether, Artif. Cells Nanomed. Biotechnol., 43, 334, 10.3109/21691401.2014.887018 · DOI · Paper page
- Himawan, 2023, Multifunctional low temperature-cured PVA/PVP/citric acid-based hydrogel forming microarray patches: physicochemical characteristics and hydrophilic drug interaction, Eur. Polym. J., 186, 10.1016/j.eurpolymj.2023.111836 · doi:10.1016/j.eurpolymj.2023.111836
- Altuntaş, 2022, Nestorone nanosuspension-loaded dissolving microneedles array patch: a promising novel approach for “on-demand” hormonal female-controlled peritcoital contraception, Int. J. Pharm., 614, 10.1016/j.ijpharm.2021.121422 · DOI
- Rojekar, 2021, Etravirine-loaded dissolving microneedle arrays for long-acting delivery, Eur. J. Pharm. Biopharm., 165, 41, 10.1016/j.ejpb.2021.04.024 · DOI
- Faizi, 2022, Deferasirox nanosuspension loaded dissolving microneedles for intradermal delivery, Pharmaceutics, 14, 2817, 10.3390/pharmaceutics14122817 · DOI
- Lutton, 2015, Microneedle characterisation: the need for universal acceptance criteria and gmp specifications when moving towards commercialisation, Drug Deliv. Transl. Res., 5, 313, 10.1007/s13346-015-0237-z · DOI · Paper page
- Peng, 2021, Hydrogel-forming microneedles for rapid and efficient skin deposition of controlled release tip-implants, Mater. Sci. Eng. C, 127, 10.1016/j.msec.2021.112226 · DOI
- Rooseboom, 2004, Enzyme-catalyzed activation of anticancer prodrugs, Pharmacol. Rev., 56, 53, 10.1124/pr.56.1.3 · DOI · Paper page
- Luo, 1997, Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil, Pharm. Res., 14, 1079, 10.1023/A:1012165731390 · doi:10.1023/a:1012165731390
- Aravagiri, 1995, Distribution of fluphenazine and its metabolites in brain regions and other tissues of the rat, Neuropsychopharmacology, 13, 235, 10.1016/0893-133X(95)00070-T · DOI
- Coulter, 2023, Enzyme-triggered l-α/d-peptide hydrogels as a long-acting injectable platform for systemic delivery of HIV/AIDS drugs, Adv. Healthcare Mater.
- Crudden, 2018, Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension, J. Control. Release, 28, 119, 10.1016/j.jconrel.2018.11.002 · DOI
- Scheff, 2011, Assessment of pharmacologic area under the curve when baselines are variable, Pharm. Res., 28, 1081, 10.1007/s11095-010-0363-8 · DOI
- Permana, 2019, Solid lipid nanoparticle-based dissolving microneedles: a promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis, J. Control. Release, 316, 34, 10.1016/j.jconrel.2019.10.004 · DOI · Paper page
- Bhadale, 2023, A comparison of dissolving microneedles and transdermal film with solid microneedles for iloperidone in vivo: a proof of concept, Naunyn-Schmiedeberg’s, Arch. Pharmacol., 396, 239, 10.1007/s00210-022-02309-0 · doi:10.1007/s00210-022-02309-0
- Pires, 2022, Antipsychotics-loaded nanometric emulsions for brain delivery, Pharmaceutics, 14, 2174, 10.3390/pharmaceutics14102174 · DOI
- Cárcamo-Martínez, 2021, Hollow microneedles: a perspective in biomedical applications, Int. J. Pharm., 599, 10.1016/j.ijpharm.2021.120455 · DOI · Paper page
- McAlister, 2021, The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis, Adv. Drug Deliv. Rev., 175, 10.1016/j.addr.2021.06.002 · DOI
- Volpe-Zanutto, 2022, Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV pre-exposure prophylaxis, J. Control. Release, 348, 771, 10.1016/j.jconrel.2022.06.028 · DOI
- Tekko, 2020, Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate, Int. J. Pharm., 586, 10.1016/j.ijpharm.2020.119580 · DOI · Paper page
- Magill, 2023, Solid implantable devices for sustained drug delivery, Adv. Drug Deliv. Rev., 199, 114950, 10.1016/j.addr.2023.114950 · DOI
- Zhang, 2023, Development of dissolving microneedles for intradermal delivery of the long-acting antiretroviral drug bictegravir, Int. J. Pharm., 642, 123108, 10.1016/j.ijpharm.2023.123108 · DOI
Cited by
Abu Ershaid, J. M., Abudoleh, S. M., Lafi, D. N., & Dahshan, N. A. (2025) · Polymers · doi:10.3390/polym17212912 · Cited by 5
Metadata
- Authors
- Abu Ershaid, J. M., Vora, L. K., Volpe-Zanutto, F., Sabri, A. H., Peng, K., Anjani, Q. K., McKenna, P. E., Ripolin, A., Larrañeta, E., McCarthy, H. O., & Donnelly, R. F.
- Venue
- Biomaterials Advances
- Publisher
- Elsevier BV
- Published
- 2023-10
- Volume
- 153
- Pages
- 213526
- ISSN
- 2772-9508
- Cited by
- 29
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microneedle array patches for sustained delivery of fluphenazine: A micron scale approach for the management of schizophrenia. https://app.cochat.ai/papers/10.1016/j.bioadv.2023.213526
- The paper
- Abu Ershaid, J. M., Vora, L. K., Volpe-Zanutto, F., Sabri, A. H., Peng, K., Anjani, Q. K., McKenna, P. E., Ripolin, A., Larrañeta, E., McCarthy, H. O., & Donnelly, R. F. (2023). Microneedle array patches for sustained delivery of fluphenazine: A micron scale approach for the management of schizophrenia. Biomaterials Advances. https://doi.org/10.1016/j.bioadv.2023.213526
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.